We are hiring!

Paraza Pharma, Inc. is growing and looking for smart passionate people to join our team. Multiple positions are available in our Chemical Sciences department. Please follow the link below to learn how to join our dynamic team!

Learn More
July 29, 2022 | News

Paraza Pharma is ISO 27001:2013 Certified

We are proud to announce that Paraza Pharma Inc. has recently achieved ISO 27001:2013 (ISO 27001) certification, one of the most globally recognized information security standards.

ISO 27001 is the international standard that sets out the specification for an Information Security Management System (ISMS).

Paraza Pharma acknowledges that confidential information is one of the most valuable assets of our client partners and our team has always maintained high standards with regards to the safe management of confidential information.  We recently decided to move one step further and underwent an extensive evaluation process which led to the establishment of a new Information Security Management System (ISMS) which was independently audited and led to Paraza’s ISO/IEC 27001:2013 certification.  ISO 27001 specifies the requirements for establishing, implementing, maintaining and continually improving an information security management system, as well as, the assessment and treatment of information security risks.

Achieving ISO 27001 confirms that our ISMS is aligned with international information security best practices and that we have the right processes and procedures in place to handle a wide range of information assets. This achievement constitutes a solid demonstration of our commitment to protect our existing and future stakeholder’s valuable information.

July 22, 2022 | News

We are honored to welcome Prof. Michel Gravel at Paraza Pharma on August 4th as part of our Paraza Lecture Series.

June 29, 2022 | News

Paraza has recently published some useful abstracts in the Heterocycles portion of SYNFACTS (Thieme Chemistry). This is an ongoing collaboration with Dr. Mark Reed at the Krembil Research Institute in Toronto to highlight useful methodologies in the recent literature for constructing pharmacologically relevant architectures.

Mark A. Reed, Andrew Burnie, Synfacts 2022; 18(07): 0726 – Gold-Catalyzed Asymmetric Annulations of Enynone Derivatives and Nitrones Generated In Situ (https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0041-1738219 )

Mark A. Reed, Nikhil D. Patil, Synfacts 2022; 18(07): 0727 – TEMPO Salt Mediated Oxidative Ugi–Azide Approach to Direct Functionalization of N-Heterocycles (https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0041-1738220)

Mark A. Reed, Nick Michel, Synfacts 2022; 18(07): 0733 – Construction of Silicon Heterocycles by Cobalt-Catalyzed Hydrosilylation of Enynes (https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0041-1738221)

Load more